Sacramento Bee Coland launched its first branded product to treat HBV in 2005, a first-to-market Adefovir generic, achieving a top-3 market position in China. Coland has actively expanded into new therapeutic areas in recent years including medical devices ... and more »
EON: Enhanced Online News (press release) In addition to these compounds, the Company's medicine BARACLUDE® ( entecavir ) is approved for the treatment of chronic hepatitis B (CHB) in adults with evidence of active viral replication and either evidence of persistent elevations in ... and more »
